Citation: Sh. Elsea, DEFINITION OF THE CRITICAL INTERVAL FOR SMITH-MAGENIS-SYNDROME (VOL 79, PG 276, 1997), Cytogenetics and cell genetics, 81(1), 1998, pp. 67-67
Citation: D. Sun et al., CLONING OF A HUMAN EPIDERMAL-TYPE 12-LIPOXYGENASE-RELATED GENE AND CHROMOSOMAL LOCALIZATION TO 17P13, Cytogenetics and cell genetics, 81(1), 1998, pp. 79-82
Authors:
ELSEA SH
FRITZ E
SCHOENERSCOTT R
MEYN MS
PATEL PI
Citation: Sh. Elsea et al., GENE FOR TOPOISOMERASE-III MAPS WITHIN THE SMITH-MAGENIS-SYNDROME CRITICAL REGION - ANALYSIS OF CELL-CYCLE DISTRIBUTION AND RADIATION SENSITIVITY, American journal of medical genetics, 75(1), 1998, pp. 104-108
Citation: E. Fritz et al., OVEREXPRESSION OF A TRUNCATED HUMAN TOPOISOMERASE-III PARTIALLY CORRECTS MULTIPLE ASPECTS OF THE ATAXIA-TELANGIECTASIA PHENOTYPE, Proceedings of the National Academy of Sciences of the United Statesof America, 94(9), 1997, pp. 4538-4542
Authors:
ELSEA SH
WESTERGAARD M
BURDEN DA
LOMENICK JP
OSHEROFF N
Citation: Sh. Elsea et al., QUINOLONES SHARE A COMMON INTERACTION DOMAIN ON TOPOISOMERASE-II WITHOTHER DNA CLEAVAGE-ENHANCING ANTINEOPLASTIC DRUGS, Biochemistry, 36(10), 1997, pp. 2919-2924
Authors:
ELSEA SH
FRITZ E
SCHOENERSCOTT R
ADELL RA
MEYN MS
PATEL PI
Citation: Sh. Elsea et al., GENETIC DISSECTION OF SMITH-MAGENIS-SYNDROME - HAPLOINSUFFICIENCY OF TOPOISOMERASE-III AND 19 NEW MARKERS AND ESTS WITHIN 17P11.2, American journal of human genetics, 61(4), 1997, pp. 702-702
Authors:
JUYAL RC
FIGUERA LE
HAUGE X
ELSEA SH
LUPSKI JR
GREENBERG F
BALDINI A
PATEL PI
Citation: Rc. Juyal et al., MOLECULAR ANALYSES OF 17P11.2 DELETIONS IN 62 SMITH-MAGENIS SYNDROME PATIENTS, American journal of human genetics, 58(5), 1996, pp. 998-1007
Authors:
FROELICHAMMON SJ
BURDEN DA
PATCHAN MW
ELSEA SH
THOMPSON RB
OSHEROFF N
Citation: Sj. Froelichammon et al., INCREASED DRUG AFFINITY AS THE MECHANISTIC BASIS FOR DRUG HYPERSENSITIVITY OF A MUTANT TYPE-II TOPOISOMERASE, The Journal of biological chemistry, 270(47), 1995, pp. 28018-28021
Citation: Sh. Elsea et al., A YEAST TYPE-II TOPOISOMERASE SELECTED FOR RESISTANCE TO QUINOLONES -MUTATION OF HISTIDINE-1012 TO TYROSINE CONFERS RESISTANCE TO NONINTERCALATIVE DRUGS BUT HYPERSENSITIVITY TO ELLIPTICINE, The Journal of biological chemistry, 270(4), 1995, pp. 1913-1920
Citation: Yc. Hsiung et al., A MUTATION IN YEAST TOP2 HOMOLOGOUS TO A QUINOLONE-RESISTANT MUTATIONIN BACTERIA - MUTATION OF THE AMINO-ACID HOMOLOGOUS TO SER(83) OF ESCHERICHIA-COLI GYRA ALTERS SENSITIVITY TO EUKARYOTIC TOPOISOMERASE INHIBITORS, The Journal of biological chemistry, 270(35), 1995, pp. 20359-20364
Authors:
ELSEA SH
JUYAL RC
JIRALERSPONG S
FINUCANE BM
PANDOLFO M
GREENBERG F
BALDINI A
STOVER P
PATEL PI
Citation: Sh. Elsea et al., HAPLOINSUFFICIENCY OF CYTOSOLIC SERINE HYDROXYMETHYLTRANSFERASE IN THE SMITH-MAGENIS SYNDROME, American journal of human genetics, 57(6), 1995, pp. 1342-1350
Authors:
JUYAL RC
FIGUERA L
ELSEA SH
HAUGE X
JIRALERSPONG S
GREENBERG F
BALDINI A
PATEL PI
Citation: Rc. Juyal et al., DEFINITION OF A CRITICAL INTERVAL FOR SMITH-MAGENIS SYNDROME, American journal of human genetics, 57(4), 1995, pp. 1244-1244
Authors:
ELSEA SH
JUYAL RC
JIRALERSPONG S
FINUCANE BM
PANDOLFO M
GREENBERG F
BALDINI A
STOVER P
PATEL PI
Citation: Sh. Elsea et al., HAPLOINSUFFICIENCY OF CYTOSOLIC SERINE HYDROXYMETHYLTRANSFERASE IN THE SMITH-MAGENIS SYNDROME, American journal of human genetics, 57(4), 1995, pp. 1380-1380
Citation: Sh. Elsea et al., MUTATION OF HIS(1012) TO TYR CONFERS RESISTANCE TO QUINOLONES IN YEAST TOPOISOMERASE-II, The FASEB journal, 8(7), 1994, pp. 10001331-10001331
Authors:
OSHEROFF N
CORBETT AH
ELSEA SH
WESTERGAARD M
Citation: N. Osheroff et al., DEFINING FUNCTIONAL DRUG-INTERACTION DOMAINS ON TOPOISOMERASE-II BY EXPLOITING MECHANISTIC DIFFERENCES BETWEEN DRUG CLASSES, Cancer chemotherapy and pharmacology, 34, 1994, pp. 190000019-190000025
Citation: Md. Linnik et al., ANALYSIS OF NEUROGENIC CONTRACTIONS INDUCED BY ML-1035 AND OTHER BENZAMIDES IN THE GUINEA-PIG NON-STIMULATED ISOLATED ILEUM, Journal of Pharmacy and Pharmacology, 46(6), 1994, pp. 491-496
Authors:
ELSEA SH
MCGUIRK PR
GOOTZ TD
MOYNIHAN M
OSHEROFF N
Citation: Sh. Elsea et al., DRUG FEATURES THAT CONTRIBUTE TO THE ACTIVITY OF QUINOLONES AGAINST MAMMALIAN TOPOISOMERASE-II AND CULTURED-CELLS - CORRELATION BETWEEN ENHANCEMENT OF ENZYME-MEDIATED DNA CLEAVAGE IN-VITRO AND CYTOTOXIC POTENTIAL, Antimicrobial agents and chemotherapy, 37(10), 1993, pp. 2179-2186